NLM Digital Collections

Search

Start Over Subjects Insurance, Pharmaceutical Services ✖Remove constraint Subjects: Insurance, Pharmaceutical Services

1. A first look at how Medicare Advantage benefits and premiums in individual enrollment plans are changing from 2008 to 2009

Publication:
Washington, D.C. : AARP Public Policy Institute, c2009
Subject(s):
Insurance Benefits -- trends
Insurance, Health -- trends
Medicare -- trends
Cost Sharing -- trends
Fee-for-Service Plans
Forecasting
Health Maintenance Organizations
Insurance, Pharmaceutical Services
Medical Savings Accounts
Medicare -- statistics & numerical data
Preferred Provider Organizations
Private Sector
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

3. Medicare and mental health: the fundamentals

Publication:
Washington, D.C. : George Washington University, [2006]
Subject(s):
Insurance Coverage
Medicare -- economics
Mental Disorders -- economics
Mental Health -- statistics & numerical data
Community Mental Health Services -- economics
Disabled Persons
Disease Management
Drug Costs
Health Expenditures
Hospitalization -- economics
Insurance, Pharmaceutical Services
Medicaid -- economics
Medicare -- statistics & numerical data
Mental Disorders -- epidemiology
Mental Disorders -- therapy
Mental Health Services -- economics
Prevalence
Psychotropic Drugs -- economics
Humans
United States
Medicare Payment Advisory Commission (U.S.)

5. The Medi-Cal prescription drug benefit: an overview

Publication:
Oakland, Calif. : California HealthCare Foundation, [2009]
Subject(s):
Health Expenditures -- trends
Insurance Benefits
Insurance, Pharmaceutical Services
Medicaid
Prescription Drugs -- economics
Adult
Aged
Child
Cost Control
Cost Sharing
Disabled Persons
Drug Costs
Drug Utilization Review
Drugs, Generic
Fee-for-Service Plans
Forecasting
Managed Care Programs
Medicare Part D
Middle Aged
Humans
California

6. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):
Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare Part B -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

7. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):
Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

8. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017
Subject(s):
Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

9. Part D plans generally include drugs commonly used by dual eligibles: 2018

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Drug Utilization
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Medicare Part D
Insurance Benefits
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
United States.

10. Pharmacogenomics: a primer for policymakers

Publication:
Washington, D.C. : George Washington University, [2008]
Subject(s):
Genetic Testing
Insurance Coverage
Pharmacogenetics -- economics
Pharmacogenetics -- trends
Information Management
Cost-Benefit Analysis
Drug Industry
Health Policy
Health Services Accessibility
Health Services Research
Insurance, Pharmaceutical Services
Pharmaceutical Preparations
Pharmacogenetics -- ethics
Safety
Humans
United States